Page 12 - Read Online

Lu et al. J Transl Genet Genom 2020;4:203-9 I http://dx.doi.org/10.20517/jtgg.2020.33 Page 209

31. Menchetti M, Rucci P, Bortolotti B, Bombi A, Scocco P, et al. Moderators of remission with interpersonal counseling or drug treatment in
primary care patients with depression: randomized controlled trial. Br J Psychiatry 2014;204:144-50.
32. Malhotra D, Sebat J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell 2012;148:1223-41.
33. Krystal JH, State MW. Psychiatric disorders: diagnosis to therapy. Cell 2014;157:201-14.
34. Desmyter S, Bijttebier S, Heeringen KV. The role of neuroimaging in our understanding of the suicidal brain. CNS Neurol Disord Drug
Targets 2013;12:921-9.
35. Lu DY, Zhu PP, Wu HY, Yarla NS, Xu B, et al. Human suicide risk and treatment study. Cent Nerv Syst Agents Med Chem 2018;18:206-12.
36. Lu DY, Che JY, Wu HY, Lu TR, Putta S. Suicide risks and prevention, neuropathogenic study. Edeweiss Psyi Open 2020;4:124.
37. Eagles JM. Light therapy and seasonal affective disorder. Psychiatry 2009;8:125-9.
38. Cao S, Lu DY, Lu TR, Yarla NS. Future directions in the field of suicide study. EC Orthopaedics 2017;6:206-8.
39. Lu DY, Lu TR, Zhu PP. Undesired neural side-effects of a drug, a chemical and genetic interrelated problem. Cent Nerv System Agent
Med Chem 2010;10:108-12.
40. Lu DY, Yarla NS, Lu TR, Varki A, Xu B, et al. Pathology and medication for human suicide. Cell Dev Biol 2019;8:201.
41. Lu DY, Zhu PP, Lu TR, Che JY. The suicidal risks and treatments, seek medications from multi-disciplinary. Cent Nerv Syst Agents Med
Chem 2016;16:231-9.